| 000 | 01501 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250516082615.0 | ||
| 264 | 0 | _c20120626 | |
| 008 | 201206s 0 0 eng d | ||
| 022 | _a1469-0691 | ||
| 024 | 7 |
_a10.1111/j.1469-0691.2012.03772.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHicheri, Y | |
| 245 | 0 | 0 |
_aAntifungal prophylaxis in haematology patients: the role of voriconazole. _h[electronic resource] |
| 260 |
_bClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases _cApr 2012 |
||
| 300 |
_a1-15 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntifungal Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAspergillosis _xprevention & control |
| 650 | 0 | 4 |
_aAspergillus _xisolation & purification |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aHematologic Neoplasms _xmicrobiology |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPyrimidines _xtherapeutic use |
| 650 | 0 | 4 |
_aTriazoles _xtherapeutic use |
| 650 | 0 | 4 | _aVoriconazole |
| 700 | 1 | _aCook, G | |
| 700 | 1 | _aCordonnier, C | |
| 773 | 0 |
_tClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases _gvol. 18 Suppl 2 _gp. 1-15 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1469-0691.2012.03772.x _zAvailable from publisher's website |
| 999 |
_c21614825 _d21614825 |
||